|
|
 |
|
Viewing report
|
|
|
|
U.S. Collagen-Based Biomaterials Markets
Frost & Sullivan, May 2002
Baby Boomers Turn to Collagen to Ease Effects of Aging
As the population of older people continues to swell with aging baby boomers, demand will rise for products and procedures that help individuals retain their youthful appearance in later life. The increasing social acceptance of cosmetic procedures will further stimulate sales for products used for aesthetic improvements. Consequently, markets for collagen-based biomaterials are expected to show steady growth over the forecast period.
This Frost & Sullivan study examines the markets for collagen-based biomaterials, specifically those used in urinary incontinence implants, corneal shields, and facial aesthetics dermal implants. By tracking key drivers and restraints and presenting expert revenue forecasts, this research gives users an essential guide in planning for the future of this expanding field.
Competition from Alternative Products Could Impede Market Growth
An increasing level of competition from substitute products threatens to shrink the market share of collagen-based medical devices in the total
biomaterials market, says the study’s author. In almost every segment, new substitute products have either entered or are expected to do so in the near future. For example, in the urinary incontinence and facial aesthetics markets collagen-based products will be forced to compete with hyaluronic acid-based products in coming years.
Participants must work hard to surpass products that promise better safety and longevity than collagen. Strategies to discount products and emphasize products established reputations must go hand in hand with research to develop alternative forms of collagen, states the analyst. This study provides in-depth discussions of challenges and offers strategic recommendations to help your company anticipate and overcome obstacles that lay ahead.
Low Medicare Reimbursement Rates Stifle Market Potential
Although an aging population will create high demand for collagen-based medical devices, low Medicare reimbursement rates will restrain unit sales an profit potential in the market, according to the author. Medicare fees for medical services will be reduced by 17 percent from 2002 to 2005.
Since many private third-party payers tailor their payout patterns to match Medicares, the damage to this marketplace will be compounded, says the analyst. By tracking emerging trends and assessing their impact on the industry, this study supplies your firm with a valuable tool for staying ahead of the uninformed competition.
Market Participants
Advanced Tissue Sciences
Alcon Laboratories, Inc.
Allergan, Inc.
American Medical System
Artes Medical, Inc.
Bard Urological Divisio
Bausch & Lomb Surgical
Bioform
Boston Scientific Corp.
Carbon Medical Technologies, Inc.
Collagenesis, Inc.
Fascia Biosystem
Genyx Medical, Inc.
Genzyme Corp.
Gore Advanced Technologies Worldwid
INAMED Corp.
Interfa
Isolagen Technologies, Inc.
LifeCell Corp.
McGhan Medical Corp.
Mentor Corp.
Metacri
Oasis Medical, Inc.
Protein Polymer Technologies, Inc.
Purac Bioche
Q-Med Canada
Q-Med Scandinavia, Inc.
Q-Med, Inc.
Regeneration Technologies, Inc.
Reprogenesi
Uromedica Corp.
Uroplasty, Inc.
Aerospac
Auto ID
Biotech
Chemicals
Conferencing
Consumer
e-Business
Environment
Food
Healthcare
Internet Security
IT
Latin America
Medical Devices
Motors
Pharmaceuticals
Power
Sensors
Smart Cards
Technical Insights
Telecom Services
Transportation
Water
Wireless
|
|
|
|
